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Abstract Contribution of sphingosine kinase (SPK)-catalyzed
production of sphingosine-1-phosphate (SPP), in comparison to
phospholipase C (PLC), to Ca2+ signalling by epidermal growth
factor (EGF) was studied in two HEK-293 cell clones (HEK2
and HEK3), expressing functional EGF receptors and exhibiting
release of stored Ca2+ by intracellular SPP. In HEK3 cells, EGF
increased [Ca2+]i and stimulated both, SPK and PLC. [Ca2+]i
increase, but not PLC stimulation, was strongly reduced by SPK
inhibition. In HEK2 cells, EGF similarly stimulated PLC, but
did not increase [Ca2+]i or stimulate SPK, suggesting that
intracellular SPP production plays a major role for Ca2+
signalling by EGF in HEK-293 cells.
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1. Introduction
In the past few years, a novel Ca2 mobilization pathway
has been proposed which involves receptor activation of
sphingosine kinase (SPK) and subsequent production of
sphingosine-1-phosphate (SPP), which can release intracellu-
larly stored Ca2. Olivera and Spiegel [1] ¢rst reported a rapid
formation of SPP upon stimulation of Swiss 3T3 cells with
platelet-derived growth factor (PDGF) or serum. Inhibition of
SPK with DL-threo-dihydrosphingosine (DHS) suppressed
PDGF- and serum-stimulated DNA synthesis, suggesting an
important role for SPK and its product SPP in growth factor-
stimulated mitogenesis. Further experiments with DHS sug-
gested that PDGF-stimulated activation of several signal
transduction components, such as mitogen-activated protein
kinase, activator protein-1 and Crk, was apparently mediated
by SPK, whereas activation of others, including receptor au-
tophosphorylation, Shc phosphorylation, Shc/Grb2 associa-
tion and activation of phosphoinositide 3-kinase, was not [2].
A speci¢c participation of SPK stimulation in receptor-
mediated Ca2 signalling was ¢rst reported for the FcORI
antigen receptor in RBL-2H3 mast cells [3], followed by sim-
ilar reports for the FcQRI receptor in U937 macrophages [4,5].
We have recently provided evidence that G protein-coupled
receptors (GPCRs) can use the SPK/SPP pathway as well for
Ca2 mobilization. In HEK-293 cells stably transfected with
M2 and M3 muscarinic acetylcholine receptors (mAChRs),
the increase in cytosolic free Ca2 concentration ([Ca2]i) in-
duced by these mAChRs was markedly inhibited by DHS and
N,N-dimethylsphingosine, another SPK inhibitor [6]. Further-
more, M2 and M3 mAChRs rapidly stimulated intracellular
SPP formation. Finally, microinjection of SPP into intact
HEK-293 cells caused rapid release of Ca2 from intracellular
stores, in a manner similar to microinjected IP3 but appar-
ently independent of IP3 receptors, and also independent of
the previously described plasma membrane sphingolipid re-
ceptors [6]. In a comparable manner, SPK-mediated intracel-
lular SPP formation is apparently involved in formyl peptide
receptor-mediated Ca2 signalling and Ca2-dependent en-
zyme release in HL-60 granulocytes [7]. As [Ca2]i increases
by several distinct GPCRs in various cell types were attenu-
ated by DHS [6], the SPK/SPP pathway seems to play a wide-
spread function for Ca2 signalling by GPCRs.
Although it is now established that plasma membrane re-
ceptors can stimulate SPK with subsequent production of
intracellular SPP, there are several open questions on the
role of this pathway, in comparison to the ubiquitous phos-
pholipase C-inositol 1,4,5-trisphosphate (PLC/IP3) pathway,
for Ca2 signalling by individual membrane receptors. The
present study analyses the Ca2 signalling pathways of epi-
dermal growth factor (EGF) receptor in HEK-293 cells, spe-
ci¢cally in two HEK-293 cell clones which were established by
Peralta and coworkers in 1988 [8]. HEK2 cells (stably express-
ing the M2 mAChR) and HEK3 cells (stably expressing the
M3 mAChR) have been and are widely used by us and others
to study signal transduction by mAChRs (see e.g. [6,9^12]).
As previous studies demonstrated that the SPK/SPP pathway
plays an important role in Ca2 signalling by the overex-
pressed mAChRs in these cells [6], we used these two HEK-
293 cell clones to analyze the Ca2 signalling pathway of the
endogenously expressed EGF receptor.
2. Materials and methods
2.1. Materials
EGF and DHS were obtained from Biomol (Hamburg, Germany).
D-erythro-[3-3H]sphingosine (18 Ci/mmol) and [3H]IP3 (21 Ci/mmol)
were purchased from New England Nuclear (Bad Homburg, Ger-
many). All other materials were from previously described sources
[6,13,14]. Stock solutions of DHS were made in methanol and diluted
in 1 mg/ml fatty acid-free bovine serum albumin.
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2.2. Cell culture
HEK2 cells (overexpressing the M2 mAChR) and HEK3 cells
(overexpressing the M3 mAChR) were cultured in Dulbecco’s modi-
¢ed Eagle’s medium (DMEM/F12), containing 10% fetal calf serum,
100 U/ml penicillin G and 0.1 mg/ml streptomycin. Two days prior to
experiments, cells were washed and cultured in the absence of serum.
Pre-treatment with pertussis toxin (PTX) was performed for the last
16^20 h of cultivation with 100 ng/ml of the toxin.
2.3. Ca2+ mobilization
[Ca2]i was determined with the £uorescent calcium indicator dye
fura-2 in a Hitachi spectro£uorimeter as described before [14]. Brie£y,
cell monolayers were washed with Hanks’ balanced salt solution
(HBSS) (118 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2,
5 mM glucose, 15 mM HEPES, pH 7.4) and the cells were detached
by a bu¡er stream. Suspended cells were loaded with 1 WM fura-2/AM
for 1 h at 37‡C in HBSS. Thereafter, cells were washed twice, resus-
pended at a density of 1U106 cells/ml and used for £uorescence meas-
urements within the next hour. [Ca2]i was measured in a continu-
ously stirred cell suspension at room temperature as described [14].
2.4. IP3 mass determination
Suspensions of HEK2 and HEK3 cells in HBSS (200 Wl, 2U106
cells) were incubated for 20 s at 37‡C. The reactions were stopped
by addition of 800 Wl of 0.625 M trichloroacetic acid. IP3 mass was
determined as described previously [15]. In short, the cells were pel-
leted by centrifugation (10 min, 800Ug) and the acid supernatants
were extracted three times with 3 ml of water-saturated diethyl ether.
The neutralized samples (200 Wl) were complemented with 50 Wl
EDTA (30 mM) and 50 Wl NaHCO3 (60 mM). IP3 mass was measured
by competition with [3H]IP3 using IP3 binding protein prepared from
bovine adrenal cortex as described [15].
2.5. Inositol phosphate formation
PLC-catalyzed production of inositol phosphates was determined in
myo-[3H]inositol-labeled cells in the presence of LiCl. HEK2 and
HEK3 cells were labeled for 48 h with 2 WCi/ml of myo-[3H]inositol.
Then, cell monolayers were washed twice with HBSS and cells were
detached by a bu¡er stream. Cell suspensions (200 Wl, 2U106 cells)
were incubated for 10 min at 37‡C in HBSS containing 10 mM LiCl
before stimulation with the respective agonists for 60 min at 37‡C.
Reactions were stopped by addition of methanol. Analysis of
[3H]inositol phosphates was performed as reported before [13].
2.6. SPP production and sphingosine uptake
Uptake of [3H]sphingosine and formation of [3H]SPP was measured
in cell suspensions essentially as reported before [6]. Cells were washed
with HBSS and detached by a bu¡er stream. The reactions were
started by addition of 100 Wl of cell suspension (0.5^1U106 cells) to
100 Wl of a reaction mixture containing 2 mg/ml bovine serum albu-
min, 1 WCi/ml [3H]sphingosine (V100 000 cpm/tube) and the respec-
tive agonists in HBSS. Incubation was for the indicated periods of
time at 37‡C. Reactions were stopped by addition of 1 ml of ice-cold
HBSS, rapid ¢ltration over glass ¢ber ¢lters (Whatman GF/C; What-
man, Maidstone, England) and a wash with 1 ml of ice-cold HBSS.
Filters were extracted twice with 3 ml methanol/chloroform (2/1) for
30 min at 37‡C. Extracts were combined and centrifuged for 10 min at
2000Ug and supernatants were dried down in a SpeedVac vacuum
centrifuge. Dried lipids were dissolved in a small volume of methanol
and applied to silica gel 60 TLC plates. Sphingosine and SPP stand-
ards were applied with the samples for identi¢cation of [3H]SPP and
[3H]sphingosine, respectively. The lipids were separated by TLC in
1-butanol/acetic acid/water (3/1/1). Standard lipids were visualized
with ninhydrin, spots were scraped o¡, and radioactivity was meas-
ured by liquid scintillation counting.
2.7. Activation of mitogen-activated protein kinase (MAP kinase)
HEK2 and HEK3 cells were detached, washed with HBSS and
resuspended at a density of 5U107 cells/ml. Aliquots of the cell sus-
pension (90 Wl) were incubated with EGF (10 Wl) for 5 min at 37‡C.
The reactions were stopped by addition of 500 Wl of lysis bu¡er (1%
SDS, 10 mM Tris-HCl, pH 7.4), followed by heating for 5 min at
95‡C and ¢ve passages through a 25-gauge needle. After removal of
insoluble material by centrifugation, the lysates were diluted with lysis
bu¡er to an equal amount of protein measured by the BCA method
(Pierce). Aliquots of the samples (30 Wg protein) were subjected to
SDS polyacrylamide gel electrophoresis using 10% acrylamide. After
blotting onto nitrocellulose membranes, the phosphorylated MAP
kinases, ERK1 and ERK2, were detected with an anti-phospho-p42/
p44 MAP kinase antibody (New England Biolabs) and visualized us-
ing an enhanced chemiluminescence detection system (Amersham,
Pharmacia Biotech Europe GmbH).
2.8. Data presentation and analysis
Data are mean þ S.E.M. from the indicated number (n) of experi-
ments performed in replicates, if not stated otherwise. The concentra-
tion-response curve in Fig. 4 was analyzed by ¢tting a sigmoidal
function to the experimental data, using iterative non-linear regression
analysis with the Prism program (GraphPad Software).
3. Results
EGF caused transient [Ca2]i elevations in HEK3 cells (Fig.
1). [Ca2]i elevations were detectable atv3 ng/ml EGF and
amounted to 71 þ 5.7 nM (n = 4) and 90 þ 6.4 nM (n = 10) at
30 ng/ml and 100 ng/ml EGF, respectively. There was a time
lag between EGF addition and peak [Ca2]i increase, which
was concentration-dependent and amounted to about 60 s at
100 ng/ml EGF. In contrast, virtually no [Ca2]i increase by
Fig. 1. Ca2 signalling by EGF in HEK3 and HEK2 cells. Shown are typical traces of [Ca2]i in suspensions of fura-2-loaded cells after stimu-
lation with 100 ng/ml EGF.
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EGF could be observed in HEK2 cells (Fig. 1). In these cells,
[Ca2]i elevations were 2.4 þ 0.9 nM (n = 16) and 3.7 þ 1.6 nM
(n = 9) at 30 ng/ml and 100 ng/ml EGF, respectively. This
di¡erence in Ca2 signalling was not due to the absence of
EGF receptors in HEK2 cells. First, addition of EGF induced
tyrosine phosphorylation of various proteins (data not shown)
and caused a similar activation of the MAP kinases, ERK1
and ERK2, in both cell lines (Fig. 2). Second, EGF stimulated
PLC in both HEK3 and HEK2 cells. Speci¢cally, EGF (30
ng/ml) increased IP3 production by 1.79 þ 0.18-fold in HEK3
cells and by 2.21 þ 0.08-fold in HEK2 cells (n = 3, Fig. 3).
Thus, in HEK2 cells lacking EGF-induced Ca2 mobilization,
EGF increased IP3 levels even slightly, although not signi¢-
cantly, more than in HEK3 cells. Similarly, EGF-induced
production of [3H]inositol phosphates was identical in
HEK3 and HEK2 cells (Fig. 3). Maximal stimulation was
observed at 30 ng/ml EGF and amounted to 1.32 þ 0.04-fold
in HEK3 cells and 1.32 þ 0.03-fold in HEK2 cells (n = 4). Tak-
en together, there was no di¡erence in EGF-induced PLC
activation between HEK3 and HEK2 cells which could ac-
count for the distinct di¡erence in EGF-stimulated Ca2 mo-
bilization. Furthermore, the di¡erence in EGF-induced Ca2
mobilization between HEK2 and HEK3 cells was apparently
not caused by the overexpressed mAChRs. Pretreatment of
the cells with the mAChR antagonist, atropine (50 WM), did
not alter the di¡erential Ca2 signalling by EGF in HEK3
and HEK2 cells (data not shown). Thus, PLC activation
was obviously not su⁄cient for Ca2 signalling by the EGF
receptor. Therefore, we examined whether HEK3 cells ex-
pressed another EGF-regulated Ca2 signalling pathway
which could explain the di¡erential Ca2 signalling pattern
observed in the two HEK-293 cell clones.
SPK stimulation has been shown to play an important role
in PDGF signalling [1,2,16] and is implicated in Ca2 signal-
ling by various receptors in di¡erent cell types [3^7]. To assess
a possible involvement of SPK in EGF-induced Ca2 signal-
ling, ¢rst, the e¡ect of the SPK inhibitor DHS [17] on EGF-
induced [Ca2]i increase in HEK3 cells was studied. Pretreat-
ment of HEK3 cells with DHS for 1 min concentration de-
pendently inhibited the EGF-induced [Ca2]i increase, reach-
ing about 65% inhibition at 40 WM DHS (Fig. 4). In contrast,
EGF (30 ng/ml)-induced [3H]inositol phosphate accumulation
was not altered by DHS. It amounted to 101% and 100% of
control values at 40 WM DHS in HEK3 and HEK2 cells,
respectively (data not shown). Next, it was studied whether
EGF activated SPK in HEK3 and HEK2 cells, by measuring
the production of [3H]SPP from [3H]sphingosine. Addition of
EGF (30 ng/ml) rapidly and transiently stimulated formation
of [3H]SPP in HEK3 cells, which was maximal at 1^2 min and
disappeared thereafter (Fig. 5B). Under the same conditions,
EGF had no e¡ect on the cellular uptake of [3H]sphingosine
(data not shown). Maximal SPK stimulation by EGF was
observed at 30 ng/ml and amounted to a 1.40 þ 0.04-fold stim-
ulation above basal (n = 7, Fig. 5C). Pretreatment of HEK3
cells with DHS inhibited both basal and EGF-stimulated
[3H]SPP formation and at 40 WM DHS the EGF receptor
stimulation was completely abolished (Fig. 5D). In contrast
to HEK3 cells, addition of EGF (30 ng/ml) did not promote
[3H]SPP formation in HEK2 cells, which was 1.03 þ 0.05-fold
above basal values (n = 4, Fig. 5A). Also at other concentra-
tions (3^100 ng/ml), EGF did not stimulate SPK in HEK2
cells (data not shown). To examine the possibility that SPP
formed after SPK stimulation with EGF might be released
and act in an autocrine manner via plasma membrane sphin-
golipid receptors, EGF-induced [Ca2]i increase was measured
in PTX-treated cells. The PTX treatment (100 ng/ml, 16^20 h)
e¡ectively blocked the [Ca2]i increase induced by extracellu-
lar SPP (1 WM), however, Ca2 signalling induced by EGF
(100 ng/ml) was not inhibited by PTX (99 þ 7.3% of control
values, mean þ S.D., n = 6). Taken together, these data suggest
that enhanced formation of intracellular SPP by SPK is re-
Fig. 2. EGF-induced MAP kinase activation in HEK3 and HEK2
cells. The cells were incubated in the absence (3) and presence (+)
of 100 ng/ml EGF for 5 min. Proteins were separated by SDS poly-
acrylamide gel electrophoresis, transferred to nitrocellulose mem-
branes, and phosphorylated ERK1 and ERK2 were detected by im-
munoblotting with an anti-phospho-MAP kinase antibody.
Fig. 3. EGF-induced PLC activation in HEK3 and HEK2 cells. Left panel, IP3 production was measured after stimulation with 30 ng/ml
EGF. Basal IP3 production was 10^20 pmol/mg protein. Right panel, [3H]inositol phosphate accumulation was measured after stimulation with
the indicated concentrations of EGF. Basal values were 300^600 cpm/mg protein. Data are from three or four experiments.
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quired for e¡ective Ca2 signalling by the EGF receptor in
HEK-293 cells.
4. Discussion
SPP has recently gained much attention as ¢rst and second
messenger [18,19]. One ¢nding of the present study is that
EGF belongs to the receptor agonists which can activate
SPK and promote intracellular SPP production. Extent and
time course of EGF-induced SPP production closely re-
sembled that of PDGF reported by others [1,16]. However,
activation of SPK by EGF was cell type speci¢c. Comparing
the two HEK-293 cell clones [8], EGF stimulated SPP pro-
duction only in HEK3 but not in HEK2 cells, although HEK2
cells express a functional EGF receptor and a receptor (M2
mAChR)-regulated SPK [6]. Similarly, in Swiss 3T3 ¢bro-
blasts, only PDGF but not EGF receptor activation stimu-
lated SPP formation, although both PDGF and EGF stimu-
lated DNA synthesis in these cells [1], but apparently by
distinct mechanisms [2]. So far, it is unclear how plasma mem-
brane receptors such as GPCRs and receptor tyrosine kinases
stimulate SPK. Recently, using various PDGF receptor mu-
tants expressed in canine kidney epithelial cells, it was shown
that SPK does not directly associate with the PDGF receptor,
but that for SPK activation tyrosine-1021 of the receptor is
required [20]. Since tyrosine-1021 mediates binding of PLCQ
to the PDGF receptor, it was suggested that SPK activation
occurs downstream of PLCQ stimulation [20]. Whether or not
this is also the case for EGF receptor-mediated SPK activa-
tion remains to be studied. As EGF stimulated SPK in HEK3
but not in HEK2 cells, while mAChR stimulation of SPK was
observed in either cell type [6], it may be speculated that in
HEK2 cells a signalling component is missing, which is spe-
ci¢cally required for SPK activation by EGF, but not by
mAChRs, and which is present in HEK3 cells. The recent
cloning of a SPK enzyme [21] will most likely also speed up
our understanding of receptor coupling mechanisms to SPK
stimulation, and thus help to resolve the question why the
EGF receptor stimulates SPK in HEK3 cells, but not in
others, i.e. HEK2 cells and Swiss 3T3 ¢broblasts.
Recent studies performed on various cell types and di¡erent
membrane receptors suggest that the SPK/SPP signal trans-
duction pathway may signi¢cantly contribute to Ca2 signal-
ling processes [3^7]. Evidence for a SPK/SPP-mediated Ca2
signalling pathway is generally based on the following three
observations. First, receptor activation leads to stimulated
production of the putative intracellular messenger. Second,
inhibition of intracellular messenger production also inhibits
Ca2 mobilization by the activated receptor. Third, intracell-
ularly applied second messenger causes release of intracellu-
larly stored Ca2. Here, we demonstrate that EGF enhances
SPP formation in HEK3 cells. Inhibition of SPK by DHS
largely attenuated EGF-induced Ca2 mobilization, while
PLC stimulation by the EGF receptor was not a¡ected. In a
previous study, we already demonstrated that intracellularly
applied SPP can release Ca2 in HEK-293 cells [6]. Thus, the
data strongly suggest that SPK contributes to EGF-stimulated
Ca2 signalling in HEK3 cells. The mechanism by which in-
tracellular SPP mobilizes Ca2 from intracellular stores is
presently unknown. A speci¢c SPP-gated Ca2 channel on
the endoplasmic reticulum has been proposed [22] but has
not yet been identi¢ed. Another possibility could be that in-
tracellularly produced SPP is secreted and activates plasma
membrane SPP receptors, which also can induce Ca2 mobil-
ization in HEK-293 cells [23]. However, this was excluded as
EGF-induced Ca2 signalling in HEK3 cells was not a¡ected
by PTX, which, on the other hand, completely abolished Ca2
mobilization induced by extracellular SPP [6,23].
Receptor-induced Ca2 signalling is generally attributed to
stimulation of the ubiquitously expressed PLC/IP3 signal
transduction pathway [24]. Since IP3-sensitive Ca2 stores
are apparently found in any mammalian cell type [25], attri-
bution of a Ca2 response induced by a given membrane
receptor to the PLC/IP3 pathway relies, in many cases, simply
on the fact that the activated receptor indeed stimulates PLC.
However, our study suggests that there is not always such a
simple one to one relationship, i.e. PLC stimulation always
results in Ca2 mobilization by the receptor. As demonstrated
here for the EGF receptor expressed in HEK2 cells, receptor-
stimulated IP3 production can occur in the absence of meas-
urable Ca2 mobilization, although functional IP3 receptors
are expressed in these cells [6]. One likely explanation is that
the level of IP3 generated by EGF stimulation is not high
enough to cause by itself a measurable [Ca2]i increase but
requires intracellular SPP as a cofactor or ampli¢cation mech-
anism for e⁄cient Ca2 mobilization. In line with this as-
sumption, we have previously demonstrated that SPK inhib-
ition by DHS suppresses M3 mAChR-induced [Ca2]i
increase only at low levels of receptor and PLC activation,
whereas at high levels of IP3 production DHS was rather
ine¡ective [6]. Furthermore, as recently reported for PDGF-
induced SPK stimulation in kidney epithelial cells [20], recep-
tor-stimulated SPP formation may require some intracellular
free Ca2, which is probably released by IP3. Such a small and
potentially localized [Ca2]i increase required for SPK stimu-
lation might have escaped the fura-2 detection method used.
Thus, we would like to suggest that for e⁄cient Ca2 mobil-
ization by the EGF receptor in HEK-293 cells activation of
both PLC and SPK is required.
On the other hand, it is also possible that PLC stimulation
Fig. 4. Inhibition of EGF-induced [Ca2]i increase by DHS. Peak
[Ca2]i increases were measured in HEK3 cells preincubated for
1 min with DHS at the indicated concentrations and stimulated
with 100 ng/ml EGF. Average increase in [Ca2]i induced by 100 ng/
ml EGF was 90 nM (see Section 3). Data are from six experi-
ments.
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does not contribute to Ca2 signalling by EGF but is needed
primarily for other purposes, such as protein kinase C activa-
tion, as was recently suggested from studies in CHO cells. In
these cells, K-thrombin and endothelin-1 stimulated PLC and
induced Ca2 mobilization. However, the [Ca2]i increase in-
duced by these two receptor agonists was not inhibited by
intracellularly applied heparin or IP3 receptor antibody, which
on the other hand e⁄ciently blocked Ca2 mobilization by
PDGF and photolyzed caged IP3 [26,27]. These data, thus,
strongly suggest that other pathways, besides the established
PLC/IP3 pathway, can mediate Ca2 signalling by membrane
receptors and, furthermore, indicate that an involvement of
the PLC/IP3 pathway in Ca2 signalling by a given receptor is
not simply indicated by the fact that the receptor is capable to
stimulate PLC.
In summary, evidence is provided that Ca2 signalling by
the EGF receptor, endogenously expressed in HEK-293 cells,
is dependent on the SPK/SPP pathway, while the EGF-stimu-
lated PLC/IP3 pathway by itself is apparently not su⁄cient for
e⁄cient Ca2 mobilization.
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